Rajesh Kumar
Stock Analyst at HSBC
(2.84)
# 1,619
Out of 5,123 analysts
29
Total ratings
52.63%
Success rate
8.39%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Downgrades: Reduce | $144 → $143 | $185.36 | -22.85% | 1 | Dec 10, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $225 → $265 | $219.02 | +20.99% | 5 | Dec 10, 2025 | |
| NVO Novo Nordisk | Downgrades: Hold | n/a | $43.34 | - | 3 | Nov 24, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $235 | $180.96 | +29.86% | 2 | Oct 9, 2025 | |
| LLY Eli Lilly and Company | Upgrades: Hold | $675 → $700 | $1,020.84 | -31.43% | 3 | Aug 27, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $28.01 | +49.95% | 1 | Apr 25, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $542.36 | +23.53% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $215.75 | +29.78% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $268.55 | +71.29% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $34.80 | -62.64% | 1 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $55 → $53 | $59.52 | -10.95% | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Reduce | $97 | $40.87 | +137.34% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $105.54 | +17.49% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $26.49 | +88.75% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $119.75 | +2.71% | 1 | Jul 14, 2023 |
Biogen
Dec 10, 2025
Downgrades: Reduce
Price Target: $144 → $143
Current: $185.36
Upside: -22.85%
AbbVie
Dec 10, 2025
Upgrades: Buy
Price Target: $225 → $265
Current: $219.02
Upside: +20.99%
Novo Nordisk
Nov 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $43.34
Upside: -
IQVIA Holdings
Oct 9, 2025
Upgrades: Buy
Price Target: $195 → $235
Current: $180.96
Upside: +29.86%
Eli Lilly and Company
Aug 27, 2025
Upgrades: Hold
Price Target: $675 → $700
Current: $1,020.84
Upside: -31.43%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $28.01
Upside: +49.95%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $542.36
Upside: +23.53%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $215.75
Upside: +29.78%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $268.55
Upside: +71.29%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $34.80
Upside: -62.64%
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $59.52
Upside: -10.95%
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $40.87
Upside: +137.34%
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $105.54
Upside: +17.49%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $26.49
Upside: +88.75%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $119.75
Upside: +2.71%